Company news
Enanta Pharmaceuticals, Inc. news in 2019
Enanta Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019
November 20, 2019
Enanta Pharmaceuticals Announces Poster Presentations at The Liver Meeting® 2019
November 10, 2019
New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions (p<0.001) in Total Symptom Score, Mucus Weight and RSV Viral Load as Measured by RT-PCR Assay and by Plaque Assay
October 2, 2019
Enanta Announces Positive Results of ARGON-1 Study of its lead FXR Agonist, EDP-305, for the Treatment of NASH
September 24, 2019
Decks in 2019
- Corporate Update (June 2019)
Corporate update · 17 slides · Jun 14, 2019